Urotherapy Education for Families of Children With Duchenne Muscular Dystrophy

NCT07821125 | Not Yet Recruiting

• 1 other identifier: 2022/12
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to investigate the effects of urotherapy education provided to families of children with Duchenne muscular dystrophy on parents' knowledge, lifestyle changes, and satisfaction with the education. Families will receive an online urotherapy education session covering lower urinary tract function, bladder and bowel habits, appropriate toileting behaviors, lifestyle recommendations, and related management strategies. Parents' knowledge and awareness will be assessed before the education, immediately after the education, and two weeks later. Satisfaction with the education will also be evaluated after the session.

Conditions

Duchenne Muscular Dystrophy (DMD); Lower Urinary Tract Symptoms (LUTS)

Keywords

Duchenne muscular dystrophy; lower urinary tract symptoms; urotherapy; education

Outcome Measures

Primary Outcomes (1)

• Change in Urotherapy Knowledge Level

  Parents' knowledge of urotherapy will be assessed using a 10-item knowledge test developed by the researchers based on the educational content. The test consists of five true/false and five multiple-choice questions. Each correct answer is worth 10 points, resulting in a total score ranging from 0 to 100. Higher scores indicate a higher level of knowledge about urotherapy.

  Baseline, two weeks after, 8 weeks after

Secondary Outcomes (2)

• Change in Urotherapy-Related Lifestyle Behaviors

  After 2 weeks and 8 weeks

• Satisfaction With Urotherapy Education

  Baseline

Study Arms (1)

Urotherapy Education Group

OTHER

Participants in this arm will receive a single online urotherapy education session lasting approximately three hours. The education will include information on lower urinary tract anatomy and function, bladder and bowel symptoms, appropriate voiding and defecation habits and postures, lifestyle modifications, fluid intake, and strategies for managing lower urinary tract symptoms. Knowledge and awareness will be assessed before the education, immediately after the education, and two weeks later and eight weeks later, and satisfaction with the education will be evaluated after the session.

Behavioral: Urotherapy Education

Interventions

Urotherapy Education BEHAVIORAL

Participants will receive a single online urotherapy education session lasting approximately three hours. The education will include information about lower urinary tract anatomy and function, lower urinary tract symptoms, bladder and bowel habits, appropriate voiding and defecation postures, scheduled voiding and defecation, fluid intake, lifestyle modifications, pelvic floor muscle awareness, and general strategies for managing lower urinary tract symptoms. Educational materials may include visual materials, videos, and other supporting resources.

Urotherapy Education Group

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Being a parent or caregiver of a child diagnosed with Duchenne muscular dystrophy.
• Volunteering to participate in the study.
• Providing informed consent.
• Being able to participate in the online urotherapy education and complete the study assessments.

You may not qualify if:

• Not completing the urotherapy education session.
• Not completing the required study assessments.

Sponsors & Collaborators

• Lokman Hekim University: lead

Study Sites (1)

Lokman Hekim University, Ankara, Ankara

Ankara, Ankara, 06370, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Muscular Dystrophy, Duchenne; Lower Urinary Tract Symptoms

Condition Hierarchy (Ancestors)

Muscular Dystrophies; Muscular Disorders, Atrophic; Muscular Diseases; Musculoskeletal Diseases; Neuromuscular Diseases; Nervous System Diseases; Genetic Diseases, X-Linked; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Urological Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Central Study Contacts

Demet Öztürk, Phd

CONTACT

905068394288; demett.ozturkk@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assist. Prof.

Model Details: A single-group pretest-posttest design will be used. All participants will receive the same online urotherapy education, with assessments conducted before the education, immediately after the education, and two weeks after the education and 8 weeks after.

Study Record Dates

• First Submitted: September 4, 2026
• First Posted: September 15, 2026
• Study Start (Estimated): November 1, 2026
• Primary Completion (Estimated): December 1, 2026
• Study Completion (Estimated): December 20, 2026
• Last Updated: September 15, 2026

Record last verified: 2026-09

Locations

TU (1)